Insta
Hong Kong Study: Pfizer-BioNTech Covid-19 Vaccine Produced Stronger Antibody Response Than Chinese-made Sinovac
Swarajya Staff
Jun 20, 2021, 04:02 PM | Updated 04:02 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
People who are vaccinated against Covid-19 with Pfizer BioNTech’s vaccine were found to have "substantially higher" levels of antibodies than those who received Sinovac vaccine, the South China Morning Post reported on Saturday (June 19), citing a major Hong Kong study.
The Hong Kong government-commissioned study was conducted by Hong Kong Univesity (HKU)’s school of public health. The study tracked the antibody responses of 1,000 people who received either vaccine. Supported by the Health and Medical Research Fund. The objective of the study was to estimate the incidence of natural infections over time and the level of population immunity due to infections and vaccinations.
“We do see substantially higher antibody responses in people who received the BioNTech vaccine, consistent with the higher levels of clinical protection reported in the large phase-three clinical trial of that vaccine, compared to the phase-three clinical trial of the Sinovac vaccine,” Benjamin Cowling, an epidemiologist with the University of Hong Kong (HKU), said.
Cowling also added that few individuals who received the Sinovac vaccine might need a third booster shot as well.
Hong Kong has administered more than 3 million doses of vaccines to residents since late February, comprising 1.7 million BioNTech jabs and 1.3 million Sinovac shots.
The BioNTech vaccine has been reported to have a 95 per cent efficacy rate, while the mark for Sinovac is 50.7 per cent.
Last week, health officials in Indonesia officials said that more than 350 medical workers have contract Covid-19 despite being vaccinated with Sinovac and dozens have been hospitalised.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.